John Cox, EVP Pharmaceutical Oper & Tech at Biogen, holds 274.18K shares in Dyne Therapeutics (Ticker: DYN), holds 0.00 shares in Sigilon Therapeutics (Ticker: SGTX), holds 923.00 shares in Repligen (Ticker: RGEN). Most recently, John Cox Bought ― shares of Dyne Therapeutics on Jul 15, 2025 for an estimated value of 911.00K.
What is the percentage of profitable transactions made by John Cox?
The percentage of profitable transactions made by John Cox is 17%.
What is the average return per transaction made by John Cox?
The average return per transaction made by John Cox is -87.90%.
What stocks does John Cox hold?
John Cox holds: BIIB, BIVV, SGTX, DYN, RGEN stocks.
What was John Cox’s latest transaction?
John Cox latest transaction was an Informative Buy of $911.00K.
What was John Cox's most profitable transaction?
John Cox’s most profitable transaction was an Informative Buy of DYN stock on July 15, 2025. The return on the trade was 21.30%.
What is John Cox's role in Biogen?
John Cox's role in Biogen is EVP Pharmaceutical Oper & Tech.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.